Skip to main content
. 2023 Feb 18;14:13. doi: 10.4103/ijpvm.ijpvm_104_22

Table 3.

Bivariate analysis of factors associated with mortality among subjects with colorectal cancer

Factors % of Death OR* 95% CI** P
Sex 0.236
 Female 58 (51.33) 1
 Male 68 (59.13) 1.37 0.81-2.32
Age (years) 0.030
An increasing and every 10 years NA*** 1.24 1.02-1.53
Marital status 0.336
 Single 4 (36.36) 1
 Married/Widow/Divorced 111 (51.15) 1.83 0.52-6.44
Religion 0.980
 Buddhism 111 (50.45) 1
 Others (Islam and Christian) 4 (50.00) 0.98 0.55-2.09
Residential area 0.428
 Rural 79 (48.77) 1
 Urban 36 (54.55) 1.26 0.71-2.24
Tumor location 0.116
 Colon (Cecum to Descending, Colon NOS) 42 (47.73) 1
 Sigmoid 21 (41.18) 0.77 0.38-1.54
 Rectum (Recto sigmoid, Rectum: NOS) 52 (58.43) 1.54 0.85-2.79
Histological type 0.959
 Other carcinoma 15 (50.00) 1
 Adenocarcinoma 100 (50.51) 1.02 0.47-2.19
Grade of differentiation 0.053
 Low 91 (47.64) 1
 High 24 (64.86) 2.03 0.98-4.22
Staging <0.001
 I and II 17 (29.82) 1
 III 37 (52.11) 2.56 1.23-5.33
 IV 20 (86.96) 15.69 4.11-59.88
 Unknown 41 (53.25) 2.67 1.30-5.52
Extension of colorectal cancer 0.141
 In situ/Localization/Direct Extension 38 (44.19) 1
 Regional Lymph Node/Distant Metastasis/Not Otherwise Specified (NOS) 77 (54.23) 1.49 0.87-2.56
Metastasis 0.567
 No 20 (46.51) 1
 Yes 95 (51.35) 1.21 0.62-2.36
Treatment <0.001
 Surgery 22 (28.57) 1
 Chemotherapy/radiotherapy 13 (56.52) 3.25 1.24-8.50
 Surgery and postoperative care 47 (50.54) 2.55 1.35-4.84
 Not surgery 33 (94.29) 41.25 9.11-186.82
Health insurance 0.952
 Government/Enterprise/Social security 34 (50.75) 1
 Universal coverage 81 (50.31) 0.98 0.56-1.74

*OR=Odds ratios, **95% CI=95 percent confidence interval, ***NA=Not available